Trial Site Detail
Drug: |
Navitoclax + Sorafenib |
|||
|---|---|---|---|---|
Trial: |
Navitoclax and Sorafenib Tosylate in Treating Patients With Relapsed or Refractory Solid Tumors |
|||
| Conditions: | Solid Neoplasm | |||
Trial Status: |
Suspended |
|||
Columbia University - Herbert Irving Cancer Center |
Navigating the Map
Use the plus (+) and minus (-) controls to zoom in/out.
Click and drag the map or use the arrows to move (pan) the map.
Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.